| P/E (FY) | — | Sales (TTM) | $2.14B |
| Earnings (TTM) | -$14.2M | ROE | −1.87% |
| Net Margin | −0.91% | ROIC | 2.14% |
| Debt / Equity | 1.00 | TD / EBITDA | 5.09 |
| EPS Growth 3Y | — | Sales Growth 3Y | 12.57% |
RadNet, with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally through two segments, Imaging Centers and Digital Health. Its services include MRI, CT, PET, nuclear medicine, mammography, ultrasound, diagnostic radiology, and fluoroscopy. The company also develops and sells computerized image distribution and picture archiving systems, AI suites that enhance radiologist interpretations of breast, lung, and prostate images, and AI-powered health informatics solutions.
| Market Cap | $4.97B | Trading Days | 5292 |
| 52W High | 85.84 |
| 52W Low | 50.76 |
| % Off High | −26.35% |
| YTD | −11.39% | 1Y | 9.32% |
| 3Y | 94.70% | 5Y | 83.09% |
| 10Y | 958.96% | Since incept. (ann.) | 23.08% |
Imaging Centers 97% · Digital Health 3%
| Ann. Volatility (1Y) | 44.80% | Ann. Volatility (3Y) | 43.47% |
| Sharpe (1Y) | 0.42 | Sharpe (3Y) | 0.72 |
| Max Drawdown (1Y) | −38.60% | Max Drawdown (3Y) | −46.84% |
| Beta (3Y, vs SPY) | 1.81 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| VCYT | VERACYTE, INC. | $4.44B | 67.9 |
| CAI | Caris Life Sciences, Inc. | $4.41B | — |
| CELC | Celcuity Inc. | $4.02B | — |
| BLLN | BillionToOne, Inc. | $2.84B | 380.6 |
| GRAL | GRAIL, Inc. | $2.76B | — |
| FTRE | Fortrea Holdings Inc. | $1.96B | — |
| CDNA | CareDx, Inc. | $1.85B | — |
| GH | Guardant Health, Inc. | $19.04B | — |
| PSNL | Personalis, Inc. | $1.24B | — |
| LMRI | Lumexa Imaging Holdings, Inc. | $1.05B | — |
| LH | LABCORP HOLDINGS INC. | $25.77B | 30.0 |
| DGX | QUEST DIAGNOSTICS INC |
| $26.04B |
| 27.0 |